Compare · head to head
Maravai LifeSciences Holdings vs Moderna
Maravai LifeSciences Holdings ranks higher overall — 360 rank 35 vs 20.
Moderna leads on Quality (39 vs 34). Maravai LifeSciences Holdings leads on Growth (68 vs 46). The two are close on Value, Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Biotechnology |
| Size | Medium | X-Large |
| ISIN | US56600D1072 | US60770K1079 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 35 | 20 |
| Value | 42 | 43 |
| Quality | 34 | 39 |
| Growth | 68 | 46 |
| Safety | 36 | 39 |
| Sentiment | 53 | 49 |
| Quality details | ||
| Profitability | 27 | 24 |
| Cash Truth | 42 | 53 |
Maravai LifeSciences Holdings vs Xeris PharmaceuticalsMaravai LifeSciences Holdings vs Sarepta TherapeuticsMaravai LifeSciences Holdings vs NovavaxMaravai LifeSciences Holdings vs PTC TherapeuticsAdd a third stock →
Full analyses: Maravai LifeSciences Holdings · Moderna
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100